New report examines opioid-related malpractice claims to identify risk factors, warning signs, and vulnerabilities in pain management.
Coverys, a medical liability insurer headquartered in Boston, released a report exploring opioid-related malpractice to identify major risk factors, warning signs, and safety vulnerabilities within the pain management process.
Ann Lambrecht, RN, BSN, JD, FASHRM, and Sharon Gilmore, MHA, BSN, RN-BC, CPHQ, CPHRM, senior risk specialists at Coverys tell Managed Healthcare Executive ®, that Covery wanted to research practice changes that can improve patient safety while reducing malpractice exposure to opioid-prescribing clinicians.
The report examines five years of closed claims, identifying 165 patient events involving opioids, and offers risk management recommendations for each stage.
According to Lambrecht and Gilmore, the report’s main findings were that providers need a specific plan for every step in the medication process and that Coverys’ claims data demonstrates the significant cost of not following national opioid prescribing guidelines.
More findings show:
Opioid events have profound impact on patient outcomes. For example, half of all opioid-related events involve a high severity patient injury, including death. In addition, opioids have caused a profound financial impact of $78.5 billion spent per year, Gilmore and Lambrecht say.
Because of opioids, more than half of all events involve errors in more than one phase of care.
Based on the information in the report, it’s critical that an initial step would be to either perform an opioid medication process self-assessment, which is an assessment to identify exposures existing in an organization.
Briana Contreras is associate editor for Managed Healthcare Executive®.